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Abstract
Two new flavonoids, (2S)-3’,4’,7,8-tetrahydroxyflavanone 7-O-(6’’-O-acetyl)-β-D-glucopyranoside
(1)  and  3’,4’,7,8-tetrahydroxyflavone  7-O-(6’’-O-acetyl)-β-D-glucopyranoside  (2)  along  with
fourteen known compounds were isolated from  Andromachia igniaria aerial  part extracts.  Their
structures  were  determined  via  spectroscopic  analyses  including  2D  NMR.  The  hypoglycemic
properties  of  all  extracts  and  pure  compounds  were  evaluated  measuring  α-amylase  and  α-
glucosidase inhibitory effects. The n-butanol among the extracts was found to be the best inhibitor
of  both α-amylase and α-glucosidase enzymes,  while  among compounds the most  active were:
bidenoside F and luteolin 4ʹ-O-β-D–glucopyranoside as α-amylase inhibitors; eriodictyol, butein and
okanin as α-glucosidase inhibitors. Results demonstrated that A. igniaria can represent an important
natural source with high biological values, helpful to control postprandial hypoglycemia.
Keywords:  Andromachia  igniaria,  Asteraceae,  flavonoids,  α-amylase  activity,  α-glucosidase
activity
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1. Introduction
Andromachia is a genus of flowering plants in the Asteraceae family, which was recognized in
1819 as a synonym of  Liabum and placed in the Vernonieae  (Robinson and Brettell, 1973). Few
information are reported about previous investigations carried out on some species from Central and
South America of this genus, that resulted basically on the isolation of some sesquiterpene lactones,
triterpenes, and flavonoids (Bohlmann et al., 1984; Jakupovic et al., 1988; Juarez et al., 1995). As a
part of our continuing chemical and biological analyses of plants from Ecuadorian flora, A. igniaria
Humb. & Bonpl., synonym Liabum igniarum Less., was selected for a phytochemical and biological
study. This species is widely distributed in the Andes mainly from Colombia and Ecuador, between
2000  and  3500  m a.s.l.;  it’s  a  shrub,  1-3  m high,  with  bracts  separated  by  petioles,  opposite
petiolated leaves, with abundant white pubescent in the underside, top inflorescence, ligulate yellow
flower and the fruit is an achene. The name “igniaria”, that means “of fire”, comes from the intense
yellow color of the inflorescences. The leaves are used to feed guinea pigs, as well as to prepare a
special sweet bread called “pan de leche”. In popular medicine people use the leaves to wash the
body for purification, to treat headache or to heal wounds. Nevertheless, no phytochemical study on
this species was reported in the literature.
Recently,  low  molecular  weight  plant-derived  molecules  such  as  luteolin  and  green  tea
polyphenols have been shown to be helpful for treating hyperglycemia  (Lo Piparo et al., 2008).
Diabetes mellitus is a major chronic disease induced by an unsuitable balance of blood glucose with
a  significant  impact  on  health.  Type  1  diabetes  is  an  insulin-dependent  disease,  while  type  2
diabetes  is  a  non-insulin-dependent  disease  characterized  by hyperglycemia  which results  from
insufficient or inefficient insulin secretion. The first can effectively be controlled by the regulation
of insulin while the management of type 2 diabetes is more difficult. One of the available therapy is
directed  to  decrease  postprandial  hyperglycemia  by  delaying  the  absorption  of  glucose,
accomplished by inhibition of starch breakdown enzymes such as α-amylase and α-glucosidase. In
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fact the inhibition of these two enzymes by pharmaceutical agents (e.g. acarbose) is an accepted
clinical strategy for managing postprandial glycemia in patients affected by type 2 diabetes. The
increasing prevalence of type 2 diabetes mellitus and the negative clinical outcomes observed with
the commercially  available  anti-diabetic  drugs  have led to  the investigation of  new therapeutic
approaches focused on controlling postprandial glucose levels. The use of carbohydrate digestive
enzyme inhibitors from natural resources could be a possible strategy to block dietary carbohydrate
absorption with less adverse effects than synthetic drugs, and plant-derived materials have been
demonstrated to be alternative to synthetic drugs due to their bioactive substances (Lee et al., 2015).
Based on this evidence, in this paper, we describe the isolation and structural characterization of
two  new  natural  flavonoids,  (2S)-3’,4’,7,8-tetrahydroxyflavanone  7-O-(6’’-O-acetyl)-β-D-
glucopyranoside (1) and 3’,4’,7,8-tetrahydroxyflavone 7-O-(6’’-O-acetyl)-β-D-glucopyranoside (2),
together  with  fourteen  known  compounds  (3-16)  (Fig.  1),  and  their hypoglycemic  properties
measuring α-amylase and α-glucosidase inhibitory effects.
2. Results and Discussion
The aerial  parts of  A. igniaria were sequentially extracted with solvents of increasing polarity
giving  n-hexane (ER), chloroform (CR), chloroform-methanol (9:1) (CMR), and methanol (MR)
residues.  The  MR  was  partitioned  between  n-BuOH  (BuR)  and  H2O  (WR). To  evaluate  the
potential  biological  activity of  A. igniaria,  all  extracts were tested for their ability to inhibit  α-
amylase  and  α-glucosidase  enzymes  at  different  concentrations.  CMR,  BuR  and  MR  extracts
demonstrated to be able to inhibit the two enzymes in a concentration-dependent manner as reported
in Figure 2, while the ER, CR and WR were inactive (data not shown). Acarbose, used as reference
drug, was more effective than CMR, BuR and MR extracts to inhibit α-amylase (Fig. 2a), whereas
CMR and BuR extracts exerted higher  α-glucosidase inhibitory activity than acarbose (Fig. 2b)
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demonstrating the biological potential of this species. Among all extracts, BuR was found to be the
most active inhibitor of both enzymes, showing the lowest IC50 values, 327.97 ± 23.03 µg/mL for α-
glucosidase, sensibly lower than acarbose (1104.29 ± 82.22 µg/mL) and 140.31 ± 9.14 µg/mL for α-
amylase, in this case higher than acarbose (IC50  = 7.42 ± 0.71  µg/mL). For this reason BuR and
CMR were further analysed for their secondary metabolite content by different chromatographies to
afford two new (1-2) and fourteen known compounds (3-16).
Compound 1 was obtained as a yellow powder, analyzed for the molecular formula C23H24O12 by
HRESI-MS at  m/z 491.482 [M−H]- (calcd for C23H23O12, 491.1190), which was further confirmed
by 13C NMR and DEPT spectra. The ESI MS spectrum of compound 1 showed a quasimolecular ion
peak at  m/z 491 [M-H]- and one peak at  m/z 287 [M-H-204]-,  due to the loss of one acetylated
hexose  moiety.  The UV absorption  bands  at  328 and  284  nm were  suggestive  of  a  flavanone
skeleton. In the 1H NMR spectrum, three aromatic proton signals (δ 7.04, d, J = 2.0 Hz; δ 6.92, dd, J
= 8.5, 2.0 Hz; δ 6.82, d, J = 8.5 Hz) indicated an ABX system on ring B, and these proton signals
were assigned to H-2’, H-6’ and H-5’ by HSQC analysis. Likewise, another two aromatic protons
signals (δ 7.40, d, J = 8.0 Hz; δ 6.90, d, J = 8.0 Hz) were readily assigned to H-5 and H-6 of ring A.
The 1H and 13C NMR spectra (Table 1) displayed also signals for an oxygenated methine doublet of
doublets at δ 5.45 (1H, dd, J = 12.0, 3.0 Hz, H-2), two methylene doublet of doublets at δ 3.16 (1H,
dd, J = 17.0, 12.0 Hz, H-3ax) and 2.81 (1H, dd, J = 17.0, 3.0 Hz, H-3eq), that were assigned with the
help of 1D TOCSY and DQF-COSY, together with signals of a sugar residue and an acetyl group.
These  1D NMR data,  in  combination  with  the  observed  2D NMR correlations,  suggested that
compound 1 was a flavanone having isookanin as aglycone (Agrawal, 1989). The structure of the
monosaccharide  moiety  of  compound  1 was  deduced  using  hydrolysis  followed  by  trimethyl
silylation and GC-analysis, 1D-TOCSY and DQF-COSY experiments. Thus, the chemical shifts of
the sugar resonances were attributable to one β-glucopyranosyl unit esterified at C-6 position. The
substitution sites of the glucose and acetyl residues were also confirmed by the HMBC correlations
between δ 4.98 (H-1glc) and 152.2 ppm (C-7) and δ 4.45, 4.28 (H2-6glc) and 172.0 ppm (COCH3).
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The stereochemistry of C-2 was determined as S on the basis of a negative Cotton effect at 280 nm
in the CD spectrum of 1 (Slade et al., 2005). Thus, the structure of compound 1 was unambiguously
elucidated as (2S)-3’,4’,7,8-tetrahydroxyflavanone 7-O-(6’’-O-acetyl)-β-D-glucopyranoside or 6’’-
O-acetyl-flavanomarein.
The molecular formula of compound 2 (C23H22O12) was established by 
13C NMR and HR-ESIMS
spectra (m/z 489.1041 for [M-H]-). Its NMR spectral data suggested that the acetylated sugar moiety
of compound  2  was superimposable to that of compound  1, while the aglycone was the point of
difference.  In  fact,  1H and  13C NMR spectra  (Table  1)  revealed  the  presence  of  an additional
aromatic signal (δH 6.78 s, δC 115.5), which could be easily assigned to ring C, and was consistent
with  the  presence  of  3’,4’,7,8-tetrahydroxyflavone  as  aglycone  (Yang  et  al.,  2012).  The
configuration of the sugar moiety was determined as reported for compound 1. Thus, the structure
of 2 was elucidated as 3’,4’,7,8-tetrahydroxyflavone 7-O-(6’’-O-acetyl)-β-D-glucopyranoside.
The  following  known  compounds  were  identified  by  spectral  analysis  and  comparison  with
published spectroscopic data:  rutin (3)  (Agrawal, 1989),  kaempferol 3-O-β-D-glucopyranoside (4)
(Agrawal, 1989),  3-β-D-glucopyranosyloxy-1-hydroxy-6(E)-tetradecene 8,10,12-triyne (5) (Rücker
et al., 1992), eugenyl O-β-D-glucopyranoside (6) (Fujita et al., 1994), 2-β-D-glucopyranosyloxy-1-
hydroxytrideca-5,7,9,11-tetrayne (7) (Chiang et al., 2007), eriodictyol (8) (Agrawal, 1989), okanin
(9) (Chokchaisiri et al., 2009), butein (10) (Chokchaisiri et al., 2009), luteolin (11) (Agrawal, 1989),
bidenoside F (12) (Li et al., 2005), caffeic acid methyl ester (13) (Saleem et al., 2004), okanin 4’-O-
β-D-glucopyranoside  (14) (Hoffmann  and  Holzl,  1988),  luteolin  4’-O-β-D-glucopyranoside (15)
(Nawwar et al., 1994), and caffeic acid (16) (Saleem et al., 2004).
All  the isolated compounds were  tested to  evaluate their  starch  breakdown enzyme inhibition
ability  against  α-amylase  and  α-glucosidase.  The  inhibition  of  these  two  enzymes  has  been
measured since it’s currently used as a pharmacological approach directed to decrease postprandial
hyperglycemia by delaying the absorption of glucose. Results were expressed as IC50 (mM) and
compared  with  reference  compound  acarbose  (Fig.  3).  Several  isolated  compounds  showed  an
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interesting α-amylase (Fig. 3a) and α-glucosidase (Fig. 3b) inhibitory activity; in particular among
flavonoids, monoglycosylated derivatives (compounds 1, 2, 4, 12, 14, and 15) reported the highest
inhibitory activity against α-amylase. Interestingly, acetylene derivatives 5 and 7 were also strong in
vitro inhibitors of α-amylase (IC50 = 0.05 ± 0.003 and 0.05 ± 0.006 mM, respectively), to the best of
our knowledge there aren’t reports about the α-amylase inhibitory activity of such structures. In the
α-amylase  inhibition assay  all  tested compounds  reported  IC50 values  higher  than  acarbose  but
lower than the extract they come from, except compound  3  which presents the highest IC50value
(0.90 ± 0.08 mM) accordingly to previous study  (Jo et  al.,  2009).  Instead, in the  α-glucosidase
inhibition test, all compounds reported IC50 values lower than acarbose and extracts. The chalcones
9 and  10  showed the highest  α-glucosidase inhibition activity with IC50 values around 0.02 mM.
Also in this case compound 3 has the highest IC50 (0.40 ± 0.03 mM). On the other hand, eugenyl O-
β-D-glucopyranoside (6) showed no inhibitory capacity against both tested enzymes. In conclusion,
both CMR and BuR extracts and their pure compounds showed a higher inhibitory capacity against
α-glucosidase than α-amylase.  Okanin (9) and butein (10),  belonging to the class of chalcones,
reported  a  good  in  vitro  α-glucosidase  inhibition,  while  flavonoids  and  the  two  acetylenes
glycosylated derivatives (5 and 7), were more effective against α-amylase. The two new compounds
1 and 2 demonstrated to be able to inhibit α-glucosidase better than acarbose, but they needed to be
more concentrated than the reference standard to reach the α-amylase IC50 value.
The activity  demonstrated  by  A. ignaria  extracts  appears  to  be of  interest  compared  to other
previously  investigated  extracts,  belonging  to  the  same  family.  For  example,  Matricaria
chamomilla hot water extract demonstrated an α-amylase IC50 value that is one order of magnitude
higher than A. ignaria BuR (5200 µg/mL vs 140.31 µg/mL respectively) (Kato et al., 2008). Finally,
the  A. ignaria  polar extracts might be used for the design of novel functional foods with blood-
glucose-lowering potential, which could be useful as a complement of other antidiabetic drugs.
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3. Experimental
3.1. General experimental procedures
Optical rotations were measured on a Perkin-Elmer 241 polarimeter equipped with a sodium lamp
(589  nm)  and  a  1  dm  microcell.  UV  spectra  were  recorded  on  a  Perkin-Elmer-Lambda
spectrophotometer. CD spectra were measured on a JASCO J-810 spectropolarimeter with a 0.1 cm
cell in MeOH at room temperature under the following conditions: speed 50 nm/min, time constant
1 s, bandwidth 2.0 nm. NMR experiments were performed on a Bruker DRX-600 spectrometer at
300 K. The standard pulse sequence and phase cycling were used for DQF-COSY, TOCSY, HSQC,
and HMBC experiments. ESI-MS were obtained using a Finnigan LC-Q Advantage Termoquest
spectrometer, equipped with Xcalibur software. HR-ESIMS were acquired in positive and negative
ion mode on a Q-TOF premier spectrometer (Waters-Milford). TLC was performed on precoated
Kieselgel 60 F254 plates (Merck); compounds were detected by spraying with Ce(SO4)2/H2SO4 and
NTS (Naturstoffe reagent)-PEG (Poliethylene glycol 4000) solutions. Column chromatography was
performed  over  Sephadex  LH-20  (Pharmacia);  reversed-phase  (RP)  HPLC  separations  were
conducted  on  a  Shimadzu  LC-8A series  pumping  system equipped  with  a  Shimadzu  RID10A
refractive index detector and a Shimadzu injector, using a C18µ-Bondapak column (30 cm x 7.8 mm,
10 µm, Waters-Milford) and a mobile phase consisting of MeOH-H2O mixtures at a flow rate of 2
mL/min. GC analyses were performed using a Dani GC 1000 instrument.  All spectrophotometric
measurements were done in 96-well microplates on a UV/VIS spectrophotometer SPECTROstarNano
(BMG Labtech) and each reaction was performed in triplicate.
3.2.Chemicals
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Sodium phosphate, sodium chloride, potassium sodium tartrate tetrahydrate,  3,5-dinitrosalicylic
acid, sodium hydroxide,  α-amylase from hog pancreas starch,  α-glucosidase from  Saccharomices
cerevisiae,  potassium phosphate  monobasic,  4-nitrophenyl  α-D-glucopyranoside,  acarbose,  NTS
(Naturstoffe  reagent),  PEG (Poliethylene  glycol  4000),  cerium disulfate  and sulfuric  acid were
acquired  from  Sigma-Aldrich  (Milano,  Italy).  Solvent  as  n-hexane,  n-butanol,  methanol,
hydrochloric acid, chloroform and glacial acetic acid were purchased from VWR (Milano, Italy).
3.3 Plant material
Aerial parts of A. igniaria were collected in Tumbaco, Ecuador in September 2011. The plant was
identified at the Herbarium of Jardin Botanico de Quito, Quito, Ecuador. A voucher specimen (N.
9371 Andromachia igniaria /1) was deposited at Herbarium Horti Botanici Pisani, Pisa, Italy.
3.4. Extraction and isolation
The dried and powdered aerial parts (580 g) of  A. igniaria were in sequence extracted for 48 h
using n-hexane, CHCl3, CHCl3-MeOH (9:1), and MeOH by exhaustive maceration (3 x 2 L), to give
8.2 (ER), 14.9 (CR), 6.3 (CMR) and 23.1 g (MR) of the respective residues. The MR extract was
partitioned between n-BuOH (BuR) and H2O (WR) to afford a n-BuOH residue. The BuR fraction
(4 g) was submitted to Sephadex LH-20 column (3 x 100 cm, flow rate 1.0 mL/min) using MeOH
as eluent to obtain sixteen major fractions  (A-P) grouped by TLC. Fraction G (109.2 mg) was
subjected to RP-HPLC with MeOH-H2O (45:55) as eluent yielding a new flavonoid (2S)-3’,4’,7,8-
tetrahydroxyflavanone  7-O-(6’’-O-acetyl)-β-D-glucopyranoside  (1,  4.3  mg, tR =  10  min  ),  and
caffeic acid methyl ester (13, 1.9 mg, tR = 14 min), rutin (3, 2.7 mg, tR = 15 min) and kaempferol 3-
O-β-D-glucopyranoside (4, 0.9 mg, tR = 21 min) . Fractions A (215.2 mg), B (136.8 mg), N (20.3
mg) and P (25 mg) were separately purified by RP-HPLC with MeOH-H2O (1:1) as eluent to give
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3-β-D-glucopyranosyloxy-1-hydroxy-6(E)-tetradecene  8,10,12-triyne  (5,  2.2 mg,  tR =  35  min),
eugenyl  O-β-D-glucopyranoside  (6,  1.5 mg,  tR =  10  min)  from  fraction  A,  2-β-D-
glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne (7, 0.8 mg, tR = 38 min) from B, eriodictyol
(8, 1.9 mg, tR = 12 min) from N, and okanin (9, 1.4 mg, tR = 13 min), butein (10, 17.3 mg, tR = 22
min) and luteolin (11, 0.3 mg, tR = 25 min) from fraction P. Fractions E (70.9 mg), I (143.3 mg), J
(424.9 mg) and L (67.9 mg) were also subjected to to RP-HPLC with MeOH-H2O (45:55) as eluent
to obtain bidenoside F (12,  1.3 mg,  tR = 13 min) from E, kaempferol  3-O-β-D-glucopyranoside
(4,1.8 mg, tR = 20 min), from J, okanin 4’-O-β-D-glucopyranoside (14, 14.2 mg, tR = 12 min) and
luteolin 4’-O-β-D-glucopyranoside (15, 1.1 mg, tR = 23 min) from fraction L.
The CMR extract  (6  g)  was  subjected  to  Sephadex LH-20 column (3 x 100 cm, flow rate 1
mL/min) eluting with MeOH to give eleven major fractions (A-K) grouped by TLC, together with
pure  luteolin  (11,  11.6 mg).  Fraction E (232 mg) was purified by RP-HPLC with MeOH-H2O
(55:45) as eluent to afford 3-β-D-glucopyranosyloxy-1-hydroxy-6(E)-tetradecene 8,10,12-triyne (5,
1 mg,  tR = 23 min). Fraction G (130.7 mg) was purified by RP-HPLC with MeOH-H2O (2:3) as
eluent yielding compound 1 (1 mg, tR = 16 min). Fraction H (108 mg) was subjected to RP-HPLC
with MeOH-H2O (45:55) as eluent to give compound 1 (1.1 mg, tR = 10 min) and caffeic acid (16,
5.3 mg, tR = 6 min). Finally fraction I (34.1 mg) was purified by RP-HPLC with MeOH-H2O (1:1)
as  eluent  to  afford  a  new  flavonoid  3’,4’,7,8-tetrahydroxyflavone  7-O-(6’’-O-acetyl)-β-D-
glucopyranoside (2,  2 mg,  tR = 18 min).  All the compounds met the criteria of ≥ 95% purity, as
inferred by HPLC and NMR analyses.
3.4.1.(2S)-3’,4’,7,8-tetrahydroxyflavanone  7-O-(6’’-O-acetyl)-β-D-glucopyranoside  (1):  yellow
amorphous powder; -40 (c 0.4, MeOH); UV (MeOH) λmax (log ε): 328 (4.19), 284 (3.90); CD
[θ]25 (c 0.05, MeOH, nm) – 5200 (280 nm); 
1H and 13C NMR data, see Table 1; ESI MS m/z 491
[M-H]-,  473  [M-H-18]-,  287  [M-H-204]-,  HR  ESIMS  [M-H]- 491.1182  (calcd  for  C23H23O12
491.1190), 355.1042 [M-H-134]-, 287.0993 [M-H-204]-.
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3.4.2.  3’,4’,7,8-tetrahydroxyflavone  7-O-(6’’-O-acetyl)-β-D-glucopyranoside  (2):  yellow
amorphous powder;  -35 (c 0.078, MeOH); UV (MeOH) λmax (log ε): 258 (4.07), 321 (3.85);
1H and  13C NMR data, see  Table 1; ESI MS  m/z  489 [M-H]-; HR ESIMS  m/z 489.1041 [M-H]-
(calcd for C23H21O12 489.1033), 355.0972 [M-H-134]
-, 285.0944 [M-H-204]-.
3.5. Acid hydrolysis of compounds 1 and 2 
A solution of each compound (2.0 mg) in HCl 1 N (1 mL) was stirred at 80 °C in a stoppered
reaction vial for 4 h. After cooling, the solution was evaporated under a stream of N2. The residue
was dissolved in 1-(trimethylsilyl)imidazole and pyridine (0.2 mL), and the solution was stirred at
60 °C for 5 min. After drying the solution, the residue was partitioned between water and CHCl3.
The  CHCl3 layer  was  analyzed  by  GC  using  a  L-Chirasil-Val  column  (0.32  mm  x  25  m).
Temperatures of the injector and detector were both 200°C. A temperature gradient  system was
used for the oven, starting at 100°C for 1 min and increasing up to 180°C at a rate of 5°C/min.
Peaks of the hydrolysate were detected by comparison with retention times of authentic samples of
D-glucose (Sigma Aldrich) after treatment with 1-(trimethylsilyl)imidazole in pyridine.
3.6. Hypoglycemic activity assays
3.6.1. α-Amylase inhibitory activity
The α-amylase inhibitory activity was assayed using 10  µL of 20 mM sodium phosphate buffer
(pH 6.9 with 6 mM NaCl) containing 0.5 mg/mL of  α-amylase (50 Units/mg), the solution was
incubated at 25°C for 10 min with 10 µL of sample, resuspended in 15% methanol/buffer solution,
at  different  concentrations.  After  this preincubation,  10  µL of 1% starch solution in 20 mM of
sodium phosphate buffer, used as substrate, was added to each sample and the reaction mixtures
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were again incubated at 25 °C for 10 min. The reaction was stopped with 20 µL of dinitrosalicylic
acid color reagent. Subsequently the test tubes were incubated in a boiling water bath for 10 min
and cooled at room temperature.  After the last incubation step the reaction mixture was diluted
adding 300 µL of distilled water and the absorbance was measured at 540 nm. The absorbance of
blank (enzyme solution was added during the boiling)  and negative control  (sodium phosphate
buffer in place of sample) were recorded. Acarbose was dissolved in 15% methanol/buffer solution
at  different  concentrations,  and  it  was  used  as  positive  control.  Analyses  were  performed  in
triplicate and the final sample absorbance (A540 nm) was obtained by subtracting its corresponding
blank reading (Ranilla et al., 2010). The inhibitory activity was calculated by using the formula and
compared to the positive control:
%∈hibition=
(A 540NegativeControl – A540 Sample)
A540NegativeControl
∗100
The concentration of the sample required to inhibit the activity of the enzyme by 50% (IC50) was
calculated by nonlinear regression analysis.
3.6.2. α-Glucosidase inhibitory activity
The α-glucosidase inhibitory activity was assessed using the procedure previously reported with
slight modification (Vinholes et al., 2011). In each well 130 µL of 10 mM phosphate buffer pH 7.0
and 60 µL of substrate (2.5 mM 4-nitrophenyl α-D-glucopyranoside in 10 mM phosphate buffer)
were  added  to  40  µL  of  sample  dissolved  in  15%  methanol/buffer  solution  at  different
concentrations. The reaction was initiated by the addition of 20 µL of enzyme (0.28 U/mL in 10
mM phosphate buffer) and the plates were incubated at 37 ºC for 10 min. The absorbance was
measured at 405 nm before the addition of the enzyme (T0’) and after 10 minutes of incubation
(T10’).  Acarbose  was  dissolved  in  15% methanol/buffer  solution  (different  concentrations  were
used), and it was used as positive control. A negative control absorbance (phosphate buffer in place
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of  sample)  was  also  recorded.  The  inhibitory  activity  was  calculated  by  using  the  following
formula: 
%∈hibition=
(A405NegativeControlT 10’T 0 ’ – A 405SampleT 10’T 0 ’)
A540NegativeControlT 10 ’T 0 ’
∗100
The concentration of the sample required to inhibit the activity of the enzyme by 50% (IC50) was
calculated by nonlinear regression analysis.
3.6.3. Statistical analysis
Data  are  expressed  as  the  mean  ±  standard  error  of  the  mean  (SEM)  of  three  independent
experiments.  Data  were  considered  statistically  significant  when  p values  ≤  0.05.  Statistical
analyses were performed using GraphPad Prism 5 Software (San Diego, CA, USA) and the IC50
values were estimated by nonlinear curve-fitting and presented as their respective 95% confidence
limits.
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Legend for Figures
Fig. 1 Chemical structure of isolated compounds (1-16): (2S)-3’,4’,7,8-Tetrahydroxyflavanone 7-O-
(6’’-O-acetyl)-β-D-glucopyranoside  (1);  3’,4’,7,8-Tetrahydroxyflavone  7-O-(6’’-O-acetyl)-β-D-
glucopyranoside  (2);  Rutin  (3);  Kaempferol  3-O-β-D-glucopyranoside  (4);  3-β-D-
Glucopyranosyloxy-1-hydroxy-6(E)-tetradecene 8,10,12-triyne (5); eugenyl O-β-D-glucopyranoside
(6); 2-β-D-glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne (7);  Eriodictyol (8); Okanin (9);
Butein (10); Luteolin (11); Bidenoside F (12); Caffeic acid methyl ester (13); Okanin 4’-O-β-D-
glucopyranoside (14); 4’-O-β-D-glucopyranoside (15); Caffeic acid (16).
Fig. 2 Dose-dependent extracts α-amylase (a) and α-glucosidase (b) inhibition activities: Acarbose;
Chloroform-methanol extract (9:1) (CMR), Methanol extract (MR) and n-BuOH extract (BuR).
 
Fig. 3 α-amylase (a) and α-glucosidase (b) inhibition by isolated compounds (IC50 in mM, data are
means ± SD from three experiments): Acarbose; (2S)-3’,4’,7,8-Tetrahydroxyflavanone 7-O-(6’’-O-
acetyl)-β-D-glucopyranoside  (1);  3’,4’,7,8-Tetrahydroxyflavone  7-O-(6’’-O-acetyl)-β-D-
glucopyranoside  (2);  Rutin  (3);  Kaempferol  3-O-β-D-glucopyranoside  (4);  3-β-D-
Glucopyranosyloxy-1-hydroxy-6(E)-tetradecene  8,10,12-triyne  (5);  2-β-D-glucopyranosyloxy-1-
hydroxytrideca-5,7,9,11-tetrayne  (7);  Eriodictyol  (8);  Okanin  (9);  Butein  (10);  Luteolin  (11);
Bidenoside F (12); Caffeic acid methyl ester (13); Okanin 4’-O-β-D-glucopyranoside (14); 4’-O-β-
D-glucopyranoside (15); Caffeic acid (16).
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Table1
1H and 13C-NMR data of compounds 1 and 2 (CD3OD, 600 MHz, J in Hz)
a.
position 1 2
δH δC δH δC
2 5.45 dd (12.0, 3.0) 81.5 154.0
3ax 3.16 dd (17.0, 12.0) 44.8 6.78 s 115.5
3eq 2.81 dd (17.0, 3.0)
4 194.0 193.3
5 7.40 d (8.0) 118.3 7.22 d (8.0) 114.8
6 6.90 d (8.0) 111.0 7.09 d (8.0) 113.0
7 152.2 153.6
8 136.5 135.6
9 152.0 148.0
10 113.8 119.4
1’ 131.5 125.6
2’ 7.04 d (2.0) 115.3 7.60 d (1.8) 119.2
3’ 145.0 147.7
4’ 146.5 149.0
5’ 6.82 d (8.5) 116.5 6.86 d (8.0) 116.7
6’ 6.92 dd (8.5, 2.0) 118.6 7.39 dd (8.0, 1.8) 126.7
Glc 1 4.98 d (7.8) 102.6 5.00 d (7.8) 102.9
2 3.54 dd (9.0, 7.8) 74.7 3.60 dd (9.5, 7.8) 74.5
3 3.51 t (9.0) 77.6 3.50 t (9.5) 77.7
4 3.42 t (9.0) 71.6 3.43 t (9.5) 71.8
5 3.72 m 75.6 3.73 m 76.2
6a 4.45 dd (12.0, 3.0) 65.0 4.49 dd (12.0, 3.0) 65.0
6b 4.28 dd (12.0, 5.0) 4.30 dd (12.0, 4.5)
COCH3 172.0 172.7
COCH3 2.14 s 20.8 2.10 s 21.1
aData assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and
HMBC experiments.
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